Procedural Characteristics of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention and Their Clinical Implications

Seung-Yul Lee, Jun-Jie Zhang, Gary S Mintz, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Jing Kan, Tao Pan, Xiaofei Gao, Zhen Ge, Shao-Liang Chen, Myeong-Ki Hong, Seung-Yul Lee, Jun-Jie Zhang, Gary S Mintz, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Jing Kan, Tao Pan, Xiaofei Gao, Zhen Ge, Shao-Liang Chen, Myeong-Ki Hong

Abstract

Background Despite the clinical benefits to intravascular ultrasound (IVUS) guidance for percutaneous coronary intervention (PCI), most patients with coronary artery disease undergo angiography-guided PCI alone in the real-world setting. We sought to investigate the procedural characteristics of IVUS-guided PCI and their clinical outcomes, as compared with angiography-guided PCI. Methods and Results This was a cohort study using patient-level data from the IVUS-XPL (Impact of Intravascular Ultrasound Guidance on the Outcomes of Xience Prime Stents in Long Lesions) and ULTIMATE (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in All-Comers Coronary Lesions) clinical trials. A total of 2848 patients with 3872 native coronary lesions were included and procedural characteristics assessed by quantitative coronary angiography (QCA) were compared between IVUS and angiography guidance. Stent-to-reference vessel diameter ratio (ie, QCA stent sizing) was greater (1.11±0.16 versus 1.07±0.14, P<0.001) and high-pressure postdilation was more frequently performed (83.7% versus 75.4%, P<0.001) with IVUS guidance, whereas residual stent edge dissections were more frequent in lesions treated with IVUS guidance (4.6% versus 0.7%, P<0.001). Given the dissection risk, optimal QCA stent sizing for IVUS guidance was a stent-to-QCA reference vessel diameter ratio ≥1.1 to <1.3. Among 1424 patients (1969 lesions) treated with angiography guidance, QCA stent sizing <1.0 was observed in 651 (33.1%) lesions, while QCA stent sizing ≥1.1 to <1.3 was observed in only 526 (26.7%) lesions. Under angiography guidance, patients with both QCA stent sizing ≥1.1 to <1.3 and high-pressure postdilation (235 of 1424, 16.5%) had a lower risk of 3-year target lesion failure compared with others (hazard ratio, 0.532; 95% CI, 0.293-0.966 [P=0.038]). Conclusions IVUS-guided PCI resulted in larger QCA-assessed stent sizing and more frequent postdilation with high-pressure inflations. These procedures may further improve long-term clinical outcomes in patients undergoing PCI without IVUS. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01308281 (IVUS-XPL); NCT02215915 (ULTIMATE).

Keywords: coronary artery disease; percutaneous coronary intervention; ultrasound.

Figures

Figure 1. Optimal selection of stent size…
Figure 1. Optimal selection of stent size for intravascular ultrasound‐guided like percutaneous coronary intervention.
(A) Receiver operating characteristic curve analysis, and (B) frequency of residual stent edge dissection.
Figure 2. Frequency of stent sizing, as…
Figure 2. Frequency of stent sizing, as assessed by stent‐to‐reference vessel diameter ratio.
IVUS indicates intravascular ultrasound.
Figure 3. Cumulative incidence of target lesion…
Figure 3. Cumulative incidence of target lesion failure (TLF) at 3 years in patients undergoing angiography guidance, according to stent sizing ≥1.1 to
HR indicates hazard ratio.
Figure 4. Time‐to‐event curves for target lesion…
Figure 4. Time‐to‐event curves for target lesion failure at 3 years
(A) Intravascular ultrasound (IVUS) guidance vs angiography guidance in all patients, and (B) IVUS‐guided like procedures (stent sizing ≥1.1 to <1.3 and high‐pressure postdilation) vs others in patients undergoing angiography guidance. Hazard ratios (95% CIs) are presented.

References

    1. Maehara A, Mintz GS, Witzenbichler B, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug‐eluting stents. Circ Cardiovasc Interv. 2018;11:e006243. doi: 10.1161/CIRCINTERVENTIONS.117.006243
    1. Hong SJ, Mintz GS, Ahn CM, Kim JS, Kim BK, Ko YG, Kang TS, Kang WC, Kim YH, Hur SH, et al. Effect of intravascular ultrasound‐guided drug‐eluting stent implantation: 5‐year follow‐up of the IVUS‐XPL randomized trial. J Am Coll Cardiol Intv. 2020;13:62–71. doi: 10.1016/j.jcin.2019.09.033
    1. Gao XF, Ge Z, Kong XQ, Kan J, Han L, Lu S, Tian NL, Lin S, Lu QH, Wang XY, et al. 3‐Year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography‐guided drug‐eluting stent implantation. J Am Coll Cardiol Intv. 2021;14:247–257.
    1. Smilowitz NR, Mohananey D, Razzouk L, Weisz G, Slater JN. Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States. Catheter Cardiovasc Interv. 2018;92:E410–E415. doi: 10.1002/ccd.27673
    1. Mentias A, Sarrazin MV, Saad M, Panaich S, Kapadia S, Horwitz PA, Girotra S. Long‐term outcomes of coronary stenting with and without use of intravascular ultrasound. J Am Coll Cardiol Intv. 2020;13:1880–1890.
    1. Hong SJ, Kim BK, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Kang TS, Kang WC, Her AY, et al. Effect of intravascular ultrasound‐guided vs angiography‐guided everolimus‐eluting stent implantation: the IVUS‐XPL randomized clinical trial. JAMA. 2015;314:2155–2163. doi: 10.1001/jama.2015.15454
    1. Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S, Tian N, Lin S, Lu Q, Wu X, et al. Intravascular ultrasound versus angiography‐guided drug‐eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72:3126–3137.
    1. Holmes DR, Holubkov R, Vlietstra RE, Kelsey SF, Reeder GS, Dorros G, Williams DO, Cowley MJ, Faxon DP, Kent KM, et al. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute percutaneous transluminal coronary angioplasty registry. J Am Coll Cardiol. 1988;12:1149–1155. doi: 10.1016/0735-1097(88)92593-4
    1. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Gabriel Steg P, Morel MA, Mauri L, Vranckx P, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351. doi: 10.1161/CIRCULATIONAHA.106.685313
    1. Maehara A, Matsumura M, Ali ZA, Mintz GS, Stone GW. IVUS‐guided versus OCT‐guided coronary stent implantation: a critical appraisal. J Am Coll Cardiol Img. 2017;10:1487–1503.
    1. Kitahara H, Okada K, Kimura T, Yock PG, Lansky AJ, Popma JJ, Yeung AC, Fitzgerald PJ, Honda Y. Impact of stent size selection on acute and long‐term outcomes after drug‐eluting stent implantation in de novo coronary lesions. Circ Cardiovasc Interv. 2017;10:e004795.
    1. Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE. Differential effects of post‐dilation after stent deployment in patients presenting with and without acute myocardial infarction. Am Heart J. 2010;160:979–986. doi: 10.1016/j.ahj.2010.07.007
    1. Pasceri V, Pelliccia F, Pristipino C, Roncella A, Irini D, Varveri A, Bisciglia A, Speciale G. Clinical effects of routine postdilatation of drug‐eluting stents. Catheter Cardiovasc Interv. 2014;83:898–904. doi: 10.1002/ccd.24999
    1. Karjalainen PP, Niemela M, Laine M, Airaksinen JK, Ylitalo A, Nammas W. Usefulness of post‐coronary dilation to prevent recurrent myocardial infarction in patients treated with percutaneous coronary intervention for acute coronary syndrome (from the BASE ACS trial). Am J Cardiol. 2017;119:345–350. doi: 10.1016/j.amjcard.2016.09.057
    1. Park H, Ahn JM, Kang DY, Lee JB, Park S, Ko E, Cho SC, Lee PH, Park DW, Kang SJ, et al. Optimal stenting technique for complex coronary lesions: intracoronary imaging‐guided pre‐dilation, stent sizing, and post‐dilation. J Am Coll Cardiol Intv. 2020;13:1403–1413.
    1. Nallamothu BK, Spertus JA, Lansky AJ, Cohen DJ, Jones PG, Kureshi F, Dehmer GJ, Drozda JP, Walsh MN, Brush JE, et al. Comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the Assessing Angiography (A2) project. Circulation. 2013;127:1793–1800. doi: 10.1161/CIRCULATIONAHA.113.001952
    1. Zhang H, Mu L, Hu S, Nallamothu BK, Lansky AJ, Xu BO, Bouras G, Cohen DJ, Spertus JA, Masoudi FA, et al. Comparison of physician visual assessment with quantitative coronary angiography in assessment of stenosis severity in China. JAMA Intern Med. 2018;178:239–247. doi: 10.1001/jamainternmed.2017.7821

Source: PubMed

3
Sottoscrivi